Sun Pharmaceutical Industries has commercially launched generic Pantoprazole Sodium Delayed Release (DR) Tablets, 40 mg, which is AB-rated to Wyeth's Protonix® DR Tablets.
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/ml 10 and 30ml Multi-Dose Vials
India's Glenmark Pharmaceuticals Ltd said it received approval from the US Food and Drug Administration for its facility at Baddi in the northern Indian state of Himachal Pradesh, which manufactures ointments and creams.
Gastrotech signs Licensing Agreement with Eli Lilly following Positive Clinical Data on Compound for Irritable Bowel Syndrome
Advances technological has shaped and nature has been transformed by science and offers us unlimited potential in using environmental biotechnology – the US market for environmental biotechnology products for waste treatment is expected to be worth $180.2 million in 2008.
Swiss drugmaker Roche's key drug Avastin has received the approval for wider use to treat metastatic colorectal cancer in the European Union.
Government and private sector should join hands and carry out focused research to make India a significant player in nanotechnology said former President A P J Abdul Kalam at the conference at the National Institute of Technology at Warangal.
Union health ministry has suspended the manufacturing licence of four leading state-owned drug makers for violating the good manufacturing practices (GMP)
Sanofi-aventis’s anticoagulant Clexane® (enoxaparin sodium injection) has been approved for marketing in Japan by the Ministry of Health, Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients undergoing orthopaedic surgery of the lower limbs such as total hip replacement, total knee replacement and hip fracture surgery.
The National Pharmaceutical Pricing Authority has revised the prices of Aspirin, Sulphamethaxazole, Norfloxacin and Pyrantel Pamoate
Zydus Cadila, an innovative global pharmaceutical company, and Prolong Pharmaceuticals Inc., a US-based, venture-backed drug delivery research and development company is collaborating for the development of a next generation therapeutic protein, ‘PEG-EPO’, for the treatment of severe anemia.
Matrix Laboratories, has acquired the residual stake in Mchem group of companies, China
Shreya Life Sciences to market launch activities for Generex Oral-lyn, the non-injectable buccal insulin, from the Canada-based Generex Biotechnology Corporation in India.
Roche a world-leading healthcare provider of pharmaceuticals and diagnostics, and Ventana Medical Systems have signed a definitive merger agreement.
The National Pharmaceutical Pricing Authority (NPPA) has revised the guidelines for monitoring of prices of non-scheduled formulations, making the 10 percent ceiling in prices effective only from April 1, 2007, instead of January 2007
Suresh Sharma of Jaipur develops medicine from Kadamb tree – cure for Type II diabetes
Aurobindo Pharma has received approval from the US Food and Drug Administration (FDA) to market its 300 mg Cefdinir Capsules.
Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic has receives US Approval for treatment of High Blood Pressure
Ranbaxy Laboratories has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate Tablets, the generic version of GlaxoSmithKline's Imitrex Tablets.